Lupus kliniske forsøg i Ohio
11 studier for Lupus søger deltagere på steder i Ohio.
Byer i Ohio
Officiel studietekst (engelsk)
Study of Efficacy and Safety of LNP023 in Participants With Active Lupus Nephritis Class III-IV, +/- V
- Cleveland Clinic Foundation, Cleveland
RekruttererFase 2
Alder 18 til 100 · Alle køn · Opdateret 1. okt. 2026 · NCT05268289A Study to Test Whether Different Doses of BI 3000202 Help People With Systemic Lupus Erythematosus (SLE)
- Paramount Medical Research and Consulting, Middleburg Heights
RekruttererFase 2
Alder 18 til 74 · Alle køn · Opdateret 1. okt. 2026 · NCT07409181Phase 3 Extension Study to Evaluate Long-term Safety of Ianalumab in Participants With Systemic Lupus Erythematosus (SIRIUS-SLE Extension).
- Paramount Med Rsrch and Consult LLC, Middleburg Heights
RekruttererFase 3
Alder 12 til 100 · Alle køn · Opdateret 1. okt. 2026 · NCT06133972An Efficacy and Safety Study of Intravenous Anifrolumab to Treat Systemic Lupus Erythematosus in Pediatric Participants
- Research Site, Cincinnati
- Research Site, Cleveland
- Research Site, Columbus
RekruttererFase 3
Alder 5 til 17 · Alle køn · Opdateret 30. sep. 2026 · NCT05835310A Study of Nipocalimab in Adults With Moderate to Severe Systemic Lupus Erythematosus
- Paramount Medical Research & Consulting, Middleburg Heights
RekruttererFase 3
Alder 18 til 75 · Alle køn · Opdateret 25. sep. 2026 · NCT07438496Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
- Ohio State University Comprehensive Cancer Center, Columbus
RekruttererFase 1
Alder 18 og opefter · Alle køn · Opdateret 23. sep. 2026 · NCT03816345A Phase 2 Master Protocol Assessing Inebilizumab and Blinatumomab in Autoimmune Diseases
- MetroHealth Medical Center, Cleveland
- The Metro Health System Main Campus, Cleveland
- Cleveland Clinic Foundation, Cleveland
RekruttererFase 2
Alder 18 til 75 · Alle køn · Opdateret 21. aug. 2026 · NCT06570798A Study of GSK4527363 in Healthy Participants, Systemic Lupus Erythematosus (SLE) Participants, Healthy Chinese, and Japanese Participants and CTD-ILD Participants
- GSK Investigational Site, Columbus
RekruttererFase 1Frivillige med god helbredstilstand velkomne
Alder 18 til 65 · Alle køn · Opdateret 22. jun. 2026 · NCT06576271A Phase 1 Study of FT819 in B-cell Mediated Autoimmune Disease
- MetroHealth, Cleveland
RekruttererFase 1
Alder 12 til 70 · Alle køn · Opdateret 22. maj 2026 · NCT06308978Lupus Landmark Study: A Prospective Registry and Biorepository
- The MetroHealth System, Cleveland
RekruttererObservationsstudie
Alder 18 til 110 · Alle køn · Opdateret 15. apr. 2026 · NCT05934149BAFF CAR-T Cells (LMY-920) for Systemic Lupus Erythematosus
- Nationwide Children's, Columbus
RekruttererFase 1
Alder 18 til 65 · Alle køn · Opdateret 3. jun. 2025 · NCT06340750Fra ClinicalTrials.gov, data hentet 3. okt. 2026. Hver studie har sine egne kvalifikationskrav; studieteamet afgør, hvem der kan deltage.